Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 7,500 shares at $38.18 ($286K) on 2009-11-05, disclosed to the SEC on 2009-11-09.
Open-market sale of $286k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.18 | 2,500 | $95K | 33.3% |
| 2 | $38.18 | 5,000 | $191K | 66.7% |
| Total | $38.18 avg | 7,500 | $286K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |